Home › Macular Degeneration › New York › New York City
Macular Degeneration clinical trials in New York City, NY
3 studies for Macular Degeneration are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- New York Ear & Eye- East 85th, New York
- Northwell Health- Manhattan, Ear, Eye and Throat Hospital- Ophthalmology, New York
- Retina Associates of New York, Upper East Side, New York
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
RecruitingPhase 3
- New York Presbyterian Hospital - Columbia University Medical Center, New York
NYSCF Scientific Discovery Biobank
RecruitingObservational study
- New York Stem Cell Foundation Research Institute, New York
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Reno, NV8 studies
- Hagerstown, MD8 studies
- Sacramento, CA8 studies
- Cleveland, OH7 studies
- Fort Worth, TX7 studies
- Austin, TX7 studies
- Salt Lake City, UT7 studies
- Carmel, IN7 studies
- Houston, TX7 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.